Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Isradipine (Dynacirc): From L-Type Blockade to Translation
2026-08-20
Isradipine (Dynacirc) offers translational researchers a defined way to interrogate L-type calcium signaling across vascular and neuronal systems. By combining mechanistic pharmacology with the selectivity lessons of the v-agatoxin-IVA literature, this article presents a strategy for validating target engagement, interpreting neuroprotective phenotypes, and avoiding overextended conclusions in hypertension and neurodegenerative disease models.
-
Cytochalasin D: Actin Polymerization Inhibitor
2026-08-19
Cytochalasin D is an actin polymerization inhibitor that disrupts actin microfilaments and alters cytoskeletal processes. Product information reports a 25 nM IC50, while peer-reviewed corneal nanoparticle research supports a carefully limited use of cytoskeletal perturbation in cellular uptake studies.
-
Peptidisc-Assisted Nanobody Multimerization
2026-08-19
Chen and Duong van Hoa describe a peptidisc-assisted strategy that uses transmembrane-domain hydrophobicity to assemble nanobodies into water-soluble multimeric complexes called polybodies. The resulting assemblies improved avidity toward GFP and human serum albumin targets and supported bispecific and autofluorescent designs, expanding protein-engineering options beyond tandem fusion and conventional self-assembly scaffolds.
-
Epinephrine Bitartrate: Applied Research Workflows
2026-08-18
Build reproducible α- and β-adrenergic assays with Epinephrine Bitartrate, from concentration-response experiments to translational vasopressor modeling. This guide combines formulation control, time-resolved readouts, and lessons from the ARAMIS conversion-ratio study to improve assay interpretation without treating different vasoactive agents as interchangeable.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-18
The reference protocol establishes a standardized ex vivo whole-blood platform for testing how metabolic pathway inhibition changes immune-stimulus-induced cytokine production. Its main contribution is methodological: it preserves the cellular and soluble context of human blood while introducing controlled metabolic interventions suitable for reproducible immunometabolism research and cohort studies.
-
Triamcinolone: Protocol and QC Guide
2026-08-17
Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, storage, assay controls, and troubleshooting; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
7-AAD Cell Viability Assay Kit Guide
2026-08-17
This scenario-based guide explains how the 7-AAD Cell Viability Assay Kit, SKU K2235, supports membrane-integrity measurements in flow cytometry, microscopy, and multiplex apoptosis workflows. It connects assay design, controls, storage, interpretation, and vendor-selection considerations to practical biomedical research needs.
-
hiPSC Differentiation into Corneal Endothelial Cells
2026-08-16
This study developed a two-step, chemically defined, serum-free workflow that directs human induced pluripotent stem cells through a neural crest intermediate toward corneal endothelial cell-like cells. Its combination of TGF-β and Wnt pathway modulation with staged marker validation provides a reproducible foundation for investigating cell-based approaches to corneal endothelial dysfunction.
-
Cholecystokinin octapeptide ammonium Guide
2026-08-15
This scenario-based guide explains how Cholecystokinin octapeptide ammonium (SKU C8717) can be incorporated into receptor-focused cell viability, apoptosis, immune-response, and neurobehavioral workflows. It emphasizes identity control, concentration selection, solubility limitations, and interpretation of context-dependent results.
-
Copper Single-Atom MOF for Ultrasound-Enhanced Therapy
2026-08-14
The reference study develops FA-NH2-UiO-66-Cu, a copper single-atom nanozyme that combines glutathione depletion, peroxidase-like hydroxyl radical generation, folate-associated targeting, and ultrasound activation. Its NIR-II imaging component provides a way to track tumor-associated distribution while ultrasound improves catalytic output, offering a coordinated platform for image-informed chemodynamic therapy.
-
PGE2–Schwann Cell Dedifferentiation in PDAC PNI
2026-08-14
Wang et al. identify a paracrine PTGES–PGE2 axis through which pancreatic ductal adenocarcinoma cells induce Schwann cell dedifferentiation and a proinvasive neural microenvironment. By combining spatial and single-cell analyses with coculture and three-dimensional perturbation models, the study links PGE2-stimulated Schwann cells to LIF- and ADAMTS-1-dependent remodeling associated with perineural invasion.
-
Proteinase K Workflows for DNA and Fungal EV Research
2026-08-13
Proteinase K combines broad protein digestion with compatibility across DNA extraction and extracellular-vesicle assay workflows. This guide translates its biochemical profile into practical protocols for genomic DNA isolation, enzyme contaminant removal, and mechanistic testing of Candida albicans EV cargo.
-
N6-Methyl-dATP: Mechanism and Research Uses
2026-08-13
N6-Methyl-dATP is a methylated deoxyadenosine triphosphate analogue for controlled studies of polymerase recognition, DNA replication fidelity, and methylation-dependent nucleic-acid interactions. Its defined N6 modification and documented storage and purity specifications support reproducible in vitro assay design, but the reagent should not be presented as direct evidence of AML biology or antiviral efficacy.
-
Deracoxib: COX-2 Inhibition in Canine Research
2026-08-12
Deracoxib is a selective COX-2 inhibitor used in canine inflammation, pain, and oncology research. Evidence includes COX-2 pathway activity, cell-type-dependent antiproliferative effects, and protection of normal canine mammary epithelial cells from doxorubicin-associated toxicity in a defined in vitro model.
-
Sulfo-Cy3 NHS Ester for Vascular Assays
2026-08-12
Build cleaner protein, HDL, and antibody-tracking assays with a water-compatible Cy3 NHS ester that minimizes solubility and dye-quenching concerns. This practical guide translates the AIBP-LRP2-CXCR4 collateral-circulation findings into reproducible labeling, uptake, and troubleshooting workflows.